Latest Breaking News On - Sa noonan communications - Page 13 : comparemela.com

Autolus Therapeutics strengthens its Board with the appointment of Dr Robert Iannone as a Non-Executive Director

LONDON, June 20, 2023 Autolus Therapeutics plc , a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announces that Dr. Robert Iannone,. | June 20, 2023

City ofUnited kingdomRobert iannoneJulia wilsonConcentra biosciencesAlexandra deschnerSusana noonanJazz pharmaceuticalsSa noonan communicationsOncology at johns hopkins universityHead of researchSection head of oncology clinical developmentYale universityImmunomedics incExchange commission onExchange commission

Autolus Therapeutics Presents Positive Results from AUTO4 in Relapsed/Refractory TRBC1-Positive Peripheral T-Cell Lymphoma

At the highest dose 4 out of 4 PTCL patients achieved a response using the original manufacturing process Ongoing complete metabolic responses in 2 out of 4 patients at 15 and 18-months post-dosing at. | June 16, 2023

City ofUnited kingdomEdgar braendleKate cwynarskiSusana noonanJulia wilsonAlexandra deschnerInternational conference on malignant lymphomaConsultant haematologist university college london hospitalsSa noonan communicationsExchange commission onCardinal healthExchange commissionPositive peripheralt cell lymphomaInternational conferenceMalignant lymphoma

Autolus Therapeutics (AUTL) Reports Positive Results from AUTO4 in Relapsed/Refractory TRBC1-Positive Peripheral T-Cell Lymphoma

Autolus Therapeutics (AUTL) Reports Positive Results from AUTO4 in Relapsed/Refractory TRBC1-Positive Peripheral T-Cell Lymphoma
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

City ofUnited kingdomKate cwynarskiEdgar braendleJulia wilsonAlexandra deschnerSusana noonanCardinal healthExchange commission onConsultant haematologist university college london hospitalsSa noonan communicationsExchange commissionInternational conference on malignant lymphomaAutolus therapeuticsPositive peripheralt cell lymphomaInternational conference

Aethlon Medical to Participate in the Healthcare Virtual Conference Presented by Maxim Group and Hosted by M-Vest

/PRNewswire/ Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to diagnose and treat cancer and.

Jim frakesCharlesj fisher jrJames frakesSusan noonanPrnewswire aethlon medical incSa noonan communicationsDrug administrationCompany contactAethlon medical incMaxim groupChief executive officerChief financial officerHealthcare virtual conferenceAethlon medicalBreakthrough deviceInvestigational device exemption

Autolus to hold Annual General Meeting (AGM) of Shareholders on Friday, June 30, 2023

LONDON, June 06, 2023 Autolus Therapeutics plc , a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, has posted notice of its Annual General. | June 6, 2023

City ofUnited kingdomAlexandra deschnerJulia wilsonSusana noonanSa noonan communicationsAnnual general meetingWhite city placeAutolus therapeuticsAutolus therapeutics plc stock exchangePress releaseNnual autl us05280r1005